However, multiple tumor biomarkers utilized in clinical practice show low diagnostic accuracy for cancer, such as carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), and cytokeratin-19 fragment (CYFRA 21-1) (12–14). The gene discussed is ENO2; the disease is cancer.